Research graph
References from Development and external validation of a clinical-genetic risk identification model for rheumatoid arthritis-associated interstitial lung disease. Local targets link to admitted publications; unresolved targets remain external evidence.
Rheumatoid arthritis
10.1016/s0140-6736(23)01525-8 · 2023 · External reference
Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management
10.1183/16000617.0011-2021 · 2021 · External reference
Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years
10.1136/ard.62.8.722 · 2003 · External reference
Clinical prediction models of rheumatoid arthritis and its complications: focus on cardiovascular disease and interstitial lung disease
10.1186/s13075-023-03140-5 · 2023 · External reference
Rheumatoid arthritis related interstitial lung disease
10.1080/1744666x.2021.1905524 · 2021 · External reference
The prevalence and risk factors of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis
10.1080/07853890.2024.2332406 · 2024 · External reference
Epidemiology and clinical characteristics of interstitial lung disease in patients with rheumatoid arthritis from the JointMan database
10.1038/s41598-023-37452-y · 2023 · External reference
Clinical, epidemiological, and histopathological features of respiratory involvement in rheumatoid arthritis
10.1155/2017/7915340 · 2017 · External reference
A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality
10.1136/annrheumdis-2017-211138 · 2017 · External reference
Patterns of interstitial lung disease and mortality in rheumatoid arthritis
10.1093/rheumatology/kew391 · 2017 · External reference
Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study
10.1002/art.27405 · 2010 · External reference
Rheumatoid arthritis-associated interstitial lung disease: epidemiology, risk/prognostic factors, and treatment landscape
10.55563/clinexprheumatol/h9tc57 · 2021 · External reference
A retrospective study on the predictive implications of clinical characteristics and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease
10.1007/s10067-019-04846-1 · 2020 · External reference
Rheumatoid arthritis-associated interstitial lung disease: clinical characteristics and mortality in a large single-centre cohort
10.55563/clinexprheumatol/d8m0xv · 2025 · External reference
MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease
10.1056/nejmoa1801562 · 2018 · External reference
The association between MUC5B mutations and clinical outcome in patients with rheumatoid arthritis-associated interstitial lung disease: a retrospective exploratory study in China
10.12659/msm.920137 · 2020 · External reference
MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression
10.1016/j.semarthrit.2021.07.002 · 2021 · External reference
Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in MUC5B mutation carriers
10.1136/annrheumdis-2021-220698 · 2021 · External reference
A common MUC5B promoter polymorphism and pulmonary fibrosis
10.1056/nejmoa1013660 · 2011 · External reference
The relationship between MUC5B promoter, TERT polymorphisms and telomere lengths with radiographic extent and survival in a Chinese IPF cohort
10.1038/s41598-019-51902-6 · 2019 · External reference
The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: phase 2 methodological report
10.1002/art.27580 · 2010 · External reference
This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001
10.1164/ajrccm.165.2.ats01 · 2002 · External reference
Coumestrol induces ferroptosis to alleviate proliferation and inflammation responses of fibroblast-like synoviocytes in rheumatoid arthritis by inhibiting TRIM3-mediated down-regulation of mitochondrial PMAIP1
10.1016/j.lddd.2026.100284 · 2025 · External reference
Investigating the therapeutic potential of jiawei xuanbi decoction in rheumatoid arthritis via network pharmacology and cell experiments
10.1016/j.lddd.2025.100141 · 2025 · External reference
The lung in rheumatoid arthritis: focus on interstitial lung disease
10.1002/art.40574 · 2018 · External reference
Mortality rate in rheumatoid arthritis-related interstitial lung disease: the role of radiographic patterns
10.1186/s12890-021-01569-5 · 2021 · External reference
A risk score to detect subclinical rheumatoid arthritis-associated interstitial lung disease
10.1002/art.42162 · 2022 · External reference
Development of a prediction model for progression of rheumatoid arthritis-associated interstitial lung disease using serologic and clinical factors: the prospective KORAIL cohort
10.1016/j.semarthrit.2025.152729 · 2025 · External reference
Assessment of risk factors in patients with rheumatoid arthritis-associated interstitial lung disease
10.36416/1806-3756/e20220145 · 2022 · External reference
Rheumatoid arthritis disease activity significantly impacts on the severity of interstitial lung disease
10.1186/s13075-024-03333-6 · 2024 · External reference
Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis-related interstitial lung disease: a meta-analysis
10.1007/s10067-021-05808-2 · 2021 · External reference
Serum KL-6, CA19-9, CA125 and CEA are diagnostic biomarkers for rheumatoid arthritis-associated interstitial lung disease in the Chinese population
10.1007/s40744-021-00288-x · 2021 · External reference
Biomarkers of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis
10.3389/fimmu.2024.1455346 · 2024 · External reference
Increased production of the soluble tumor-associated antigens CA19-9, CA125, and CA15-3 in rheumatoid arthritis: potential adhesion molecules in synovial inflammation
10.1196/annals.1422.037 · 2007 · External reference
Prognostic value of serum oncomarkers for patients hospitalized with acute exacerbation of interstitial lung disease
10.1177/17534666241250332 · 2024 · External reference
Rheumatoid arthritis-associated interstitial lung disease: clinical predictive model and external validation
10.1186/s12931-025-03416-1 · 2025 · External reference
